Pluribus Labs’s Signature Bank SBNY Stock Holding History

Pluribus Labs’s Portfolio SBNY Stock Details SBNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-761	Closed	-$246K	–	244
2021 Q4	$246K	Buy	+761	New	+$237K	0.26%	172

Other funds holding SBNY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pluribus Labs's SBNY Position: Q1 2022 in Review

Pluribus Labs sold out of Signature Bank (SBNY) in Q1 2022, closing a stake of 761 shares — an estimated $246K sold.

Pluribus Labs first reported a position in SBNY in Q4 2021 and held it in 1 quarter. The position peaked at $246K in Q4 2021. 626 funds tracked by Wall St. Rank hold SBNY as of Q1 2022.

Pluribus Labs reported no remaining Signature Bank position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 761 Signature Bank shares in Q1 2022, an estimated $246K.
Pluribus Labs first reported a position in Signature Bank in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Signature Bank position peaked at $246K in Q4 2021.
626 funds tracked by Wall St. Rank held Signature Bank as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.